Data gathered: November 21
Alternative Data for Scilex Holding
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 90 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 20 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 63 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,678 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 41 | Sign up | Sign up | Sign up |
| Linkedin Employees | 107 | Sign up | Sign up | Sign up |
About Scilex Holding
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
| Price | $0.56 |
| Target Price | Sign up |
| Volume | 924,120 |
| Market Cap | $87M |
| Year Range | $0.56 - $2.15 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Drug Manufacturers |
In the news
Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C.November 17 - Finnhub |
|
 |
Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024November 14 - Yahoo |
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and DenaliNovember 6 - GlobeNewswire |
|
Scilex : Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S 4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali Form 8 KNovember 5 - Finnhub |
|
 |
Jaisim Shah Purchases 32,000 Shares of Scilex Holding (NASDAQ:SCLX) StockOctober 30 - Biztoc.com |
 |
Pleasing Signs As A Number Of Insiders Buy Scilex Holding StockOctober 30 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 16M | 4.4M | 12M | -38M | -36M | -0.262 |
| Q1 '24 | 11M | 3.8M | 7M | -24M | -23M | -0.240 |
| Q4 '23 | 13M | 4.5M | 8.9M | -21M | -20M | -0.250 |
| Q3 '23 | 10M | 3.4M | 6.7M | -36M | -34M | -0.630 |
| Q2 '23 | 13M | 4.2M | 8.4M | -27M | -22M | -0.187 |
Insider Transactions View All
| SHAH JAISIM filed to buy 109,333 shares at $1. October 29 '24 |
| Chun Jay filed to buy 112,500 shares at $1. October 18 '24 |
| Followwill Dorman filed to buy 2,300 shares at $1. October 18 '24 |
| Lemus David filed to buy 2,000 shares at $0.9. October 18 '24 |
| Ji Henry filed to buy 60,070 shares at $1. October 18 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$155.93 1.8% | 51 |
 |
Eli Lilly and CompanyLLY |
$752.32 0.1% | 65 |
 |
PfizerPFE |
$24.97 0.1% | 43 |
 |
AstrazenecaAZN |
$63.87 1.1% | 68 |
 |
AbbVieABBV |
$171.9 2.5% | 63 |
Read more about Scilex Holding (SCLX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Scilex Holding?
The Market Cap of Scilex Holding is $87M.
What is the current stock price of Scilex Holding?
Currently, the price of one share of Scilex Holding stock is $0.56.
How can I analyze the SCLX stock price chart for investment decisions?
The SCLX stock price chart above provides a comprehensive visual representation of Scilex Holding's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Scilex Holding shares. Our platform offers an up-to-date SCLX stock price chart, along with technical data analysis and alternative data insights.
Does SCLX offer dividends to its shareholders?
As of our latest update, Scilex Holding (SCLX) does not offer dividends to its shareholders. Investors interested in Scilex Holding should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Scilex Holding?
Some of the similar stocks of Scilex Holding are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.